Cumberland Pharmaceuticals Inc. (CPIX)

Market Cap	48.61M -36.3%
Revenue (ttm)	44.52M +17.6%
Net Income	-2.84M
EPS	-0.19
Shares Out	14.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,221
Open	3.200
Previous Close	3.120
Day's Range	3.150 - 3.280
52-Week Range	1.850 - 6.265
Beta	-0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 3, 2026

About CPIX

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sod...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Aug 11, 2009
• Employees: 93
• Stock Exchange: NASDAQ
• Ticker Symbol: CPIX
• Website: https://www.cumberlandpharma.com

Financial Performance

In 2025, CPIX's revenue was $44.52 million, an increase of 17.57% compared to the previous year's $37.87 million. Losses were -$2.84 million, -56.23% less than in 2024.